NANOLEK will cover the needs for inactivated polio vaccine in Russia
15 November 2017
Polymilex®, an inactivated polio vaccine, is the first IPV fully manufactured in Russia. Nanolek is implementing the project to manufacture this vaccine since 2012.
Drug sales in Russia steadily grow this year
15 November 2017
Drug sales in Russia are steadily growing this year, according to latest data of the Russian Ministry of Health, reports The Pharma Letter’s local correspondent. For the 9 months of the current year drug sales in Russia grew by 13.7% on year-on-year basis to 3.3 billion packs in value terms.
Russian State Duma approves the drug labeling bill in the first reading
14 November 2017
Russia introduces total control over the quality of drugs. This is the goal of the bill submitted by the Ministry of Health and approved by the State Duma in the first reading. The amendments include the introduction of a federal state information system for monitoring the circulation of medicines in Russia. The system will track the circulation of drugs from the manufacturers to the end consumers. To ensure this, the bill proposes to use special labeling.
13 November 2017
Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, announced that, on Friday, November 10, 2017, during the Retina Subspecialty Day of the American Academy of Ophthalmology 2017 Annual Meeting in New Orleans Charles C. Wykoff presented preliminary results from an exploratory clinical trial of CLS-TA, Clearside’s proprietary suspension formulation of the corticosteroid triamcinolone acetonide for suprachoroidal administration with and without intravitreally injected EYLEA® (aflibercept) for the treatment of diabetic macular edema.
Gottlieb: Don’t take away FDA’s drug/device approval remit for soldiers
13 November 2017
FDA Commissioner Scott Gottlieb, M.D., has hit back at plans that could see the Pentagon take control over the approval of some experimental drugs and devices for soldiers. A new policy from the Senate’s National Defense Authorization Act, which is going through committee, would allow the Pentagon to approve devices and drugs not green-lit by FDA to be used on military personnel “for emergency use.” The plans were first published this week by Politico.
Russian government proposed to increase funding for pharmaceutical industry
13 November 2017
The government has proposed to increase funding for the state program “Development of Pharmaceutical and Medical Industry” by 6.38 million rubles in 2018-2020. This results from the amendments to the draft budget prepared for the second reading in the State Duma.
Scientists developing a new approach to antibiotic resistance
10 November 2017
Antibiotic resistance to serious wound and systemic infections is a growing concern, particularly among those injured in combat. Researchers at the University of Maryland School of Medicine (UM SOM) are studying how to fend off deadly infections by targeting the body’s immune response to harmful bacteria.
FDA loosens rules on consumer genetic health tests
10 November 2017
The FDA has cleared the way for more direct-to-consumer genetic health tests to come to market. If finalized, the approach will allow certain manufacturers to bring genetic tests to market without undergoing premarket review.
ARPM and others review medicines advertising in Russia
09 November 2017
At a special session of Russia’s National Advertising Forum-2017, titled “Those who must not be named: advertising of pharmaceutical products, prohibitions and opportunities,” the principles of inter-industry self-regulation in the field of medicine advertising were discussed.
Pfizer renews 'Know Pneumonia' campaign with myth-busting creative
09 November 2017
The new TV commercial shows healthy older people asking myth-type questions, including, “Isn’t it like a bad cold or flu?” and, “Can I catch it from a pneumococcal vaccination?” A doctor—portrayed by an actor—responds to the inquisitors, telling them that it’s actually a potentially serious bacteria, and that vaccines do not contain live bacteria so no, you can’t catch it from the shot.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024